.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Mallinckrodt
McKesson
Cipla
Moodys
Argus Health
Queensland Health
Federal Trade Commission
Cantor Fitzgerald
Julphar

Generated: July 22, 2017

DrugPatentWatch Database Preview

TRUSOPT Drug Profile

« Back to Dashboard

What is the patent landscape for Trusopt, and when can generic versions of Trusopt launch?

Trusopt is a drug marketed by Merck and is included in one NDA.

The generic ingredient in TRUSOPT is dorzolamide hydrochloride. There are fourteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the dorzolamide hydrochloride profile page.

Summary for Tradename: TRUSOPT

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list36
Clinical Trials: see list11
Patent Applications: see list260
Drug Prices:see details
DailyMed Link:TRUSOPT at DailyMed

Pharmacology for Tradename: TRUSOPT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck
TRUSOPT
dorzolamide hydrochloride
SOLUTION/DROPS;OPHTHALMIC020408-001Dec 9, 1994ATRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: TRUSOPT

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck
TRUSOPT
dorzolamide hydrochloride
SOLUTION/DROPS;OPHTHALMIC020408-001Dec 9, 19944,619,939*PED► Subscribe
Merck
TRUSOPT
dorzolamide hydrochloride
SOLUTION/DROPS;OPHTHALMIC020408-001Dec 9, 19944,797,413*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: TRUSOPT

Drugname Dosage Strength RLD Submissiondate
dorzolamide hydrochlorideOphthalmic Solution2%Trusopt10/11/2005
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Baxter
Daiichi Sankyo
Teva
Mallinckrodt
Harvard Business School
QuintilesIMS
Farmers Insurance
McKinsey
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot